Abstract

Nordamnacanthal, an anthraquinone extracted from the root of Morinda el liptica from Rubiaceae family has cytotoxic properties towards cancer cell lines and antitumor promoting activities. This study was conducted to determine the cytotoxic effect of nordamnacanthal towards MOLT! 4 and MCF!7 cell lines. Nordamnacanthal was foun d to be more cytotoxic towards MOLT!4 than MCF! 7 with the IC50 of 3.8 +g/ml and 54 +g/ml, respectively, as detected by using the trypan blue dye exclusion test. The nordamnacanthal! treated cells showed characteristics of apoptosis such as membrane blebbing , chromatin condensation and formation of apoptotic bodies as observed under an inverted light microscope. Fluorescence analysis of cell death using acridine orange and propidium iodide staining showed that the population of MOLT! 4 and MCF!7 cells underwen t apoptosis at the IC50 value was 32% and 30.4%, respectively. Cell cycle analysis by flow cytometry indicated that nordamnacanthal did arrest MCF! 7 cells at the G2/M phase. For MOLT!4, no cell cycle arrest was observed. Bcl! 2 and Bax were downregulated in nordamnacanthal!treated MCF! 7 cells. On the other hand, expression of the proteins in MOLT! 4 was not significantly different from the control. In conclusion, nordamnacanthal was more cytotoxic towards MOLT!4 than MCF! 7 cell line. The compound induced apop tosis in both cell lines, but with G2/M arrest and the involvement of Bcl ! 2 and Bax only in MCF ! 7.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.